Bone marrow morphology and classification systems in myelodysplastic syndromes

Cancer Treatment Reviews

Volumn 33, Issue SUPPL. 1, 2007, Pages

  Aul, Carlo ^a   Giagounidis, Aristoteles ^a   Germing, Ulrich ^b  

^a ST JOHANNES HOSPITAL   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

FAB classification; MDS; WHO classification

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLAST CELL; BLOOD; BONE MARROW; BONE MARROW DISEASE; CLINICAL DECISION MAKING; CONTROLLED STUDY; CYTOPATHOLOGY; DISEASE CLASSIFICATION; DYSPLASIA; HEMATOPOIETIC STEM CELL; HUMAN; MORPHOLOGY; MYELODYSPLASTIC SYNDROME; PATIENT CODING; PROGNOSIS; RISK ASSESSMENT; STANDARD; WORLD HEALTH ORGANIZATION;

EID: 35848943900     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2007.07.010     Document Type: Article

References (19)

1. Brunning R.D., Bennett J.M., Flandrin G., et al. Refractory anaemia with ringed sideroblasts. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Pathology and genetics of tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon 9
2. Seymour J.F., and Estey E.H. The contribution of Auer rods to the classification and prognosis of myelodysplastic syndromes. Leuk Lymphoma 17 (1995) 79-85
3. Schaefer H.E., and Fisher R. Der Peroxydasenachweis an Ausstrichpräparaten sowie an Gewebsschnitten nach Entkalkung und Paraffineinbettung. Klin Wochenschr 46 (1968) 1228-1230
4. Van den Berghe H., Cassiman J.J., David G., et al. Distinct haematological disorder with deletion of long arm of no. 5 chromosome. Nature 251 (1974) 437-438
5. Erber W.N., Jacobs A., Oscier D.G., O'Hea A.M., and Mason D.Y. Circulating micromegakaryocytes in myelodysplasia. J Clin Pathol 40 (1987) 1349-1352
6. Aul C. Myelodysplastische Syndrome (präleukämien) (1994), Dr. Kovac, Hamburg
7. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposals for the classification of the myelodysplastic syndromes. Brit J Haematol 51 (1982) 189-199
8. Coiffier B., Adeleine P., Viala J.J., et al. Dysmyelopoietic syndromes. A search for prognostic factors in 193 patients. Cancer 52 (1983) 83-90
9. Aul C., Gattermann N., Heyll A., Germing U., Derigs G., and Schneider W. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 6 (1992) 52-59
10. Morra E., Lazzarino M., Castello A., et al. Risk assessment in myelodysplastic syndromes: value of clinical, hematologic and bone marrow histologic findings at presentation. Eur J Haematol 45 (1990) 94-100
11. Oguma S., Yoshida Y., Uchino H., Maekawa T., Nomura T., and Mizoguchi H. Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Leuk Res 19 (1995) 219-225
12. Sanz G.F., Sanz M.A., Vallespi T., et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 74 (1989) 395-408
13. Aul C., Giagounidis A., Germing U., and Ganser A. Evaluating the prognosis of patients with myelodysplastic syndromes. Ann Hematol 81 (2002) 485-497
14. Gattermann N., Aul C., and Schneider W. Two types of acquired idiopathic sideroblastic anaemia (AISA). Brit J Haematol 74 (1990) 45-52
15. Germing U., Gattermann N., Aivado M., Hildebrandt B., and Aul C. Two types of acquired idiopathic sideroblastic anaemia (AISA): a time-tested distinction. Brit J Haematol 108 (2000) 724-728
16. Bennett J.M. Classification of the myelodysplastic syndromes. Clin Haematol 15 (1986) 909-923
17. Harris N.L., Jaffe E.S., Diebold J., et al. World Health Organization of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol 17 (1999) 3835-3849
18. Nimer S.D. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q. J Clin Oncol 24 (2006) 2576-2582
19. Germing U., Gattermann N., and Strupp C. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk Res 24 (2000) 983-992